Thus, reducing NK cell levels, blocking NK cell cytotoxicity, and suppressing IFN-γ release from NK cells may slow motor neuron loss and suppress central nervous system inflammation, increasing survival in ALS. Here, IFNG is linked to amyotrophic lateral sclerosis.